The current study investigates the cooperative cardioprotective effect of calcitriol (active form of vitamin D) combined with resveratrol in a rat model of d-galactose (d.gal)-induced aging. Male Wistar rats received resveratrol (d.gal + Res), calcitriol (d.gal + Cal), or a combination of them (d.gal + Res + Cal). Intact animals served as control (Ctl). Blood pressure (BP) was recorded by cannulation of the left carotid artery. Fibrosis and cell size were assessed by Masson’s trichrome and hematoxylin–eosin staining, respectively. Cardiac and serum level of antiaging protein, klotho, was measured by ELISA assay method. Gene expression was evaluated by real-time RT-PCR. Biochemical tests were performed according to the standardized method. In d.gal + Res + Cal group, BP, heart weight-to-body weight ratio, and cardiomyocytes size decreased significantly compared with d-gal group. The cardiac transcription levels of catalase and superoxide dismutase 1 and 2 were upregulated in d.gal + Res + Cal compared to the d.gal group (P < 0.001, P < 0.05, P < 0.05, respectively). Increased level of malondialdehyde was observed in d.gal group (P < 0.01 vs. Ctl) which was normalized partially in d.gal + Res + Cal group (P < 0.05). Catalase and superoxide dismutase activity also increased in d.gal + Res + Cal group (P < 0.01 vs. d.gal). Cardiac Klotho, as the antiaging protein, remained unchanged at mRNA and protein levels among the experimental groups. The serum level of Klotho did not change significantly in d.gal group; however, in d.gal + Res + Cal group, serum klotho concentration was increased (P < 0.05 vs. d.gal). It could be concluded that co-administration of resveratrol and vitamin D protects the heart against aging-induced damage by the modulation of hemodynamic parameters and antioxidant status of the heart. Furthermore, increased serum level of klotho could be a novel mechanism for antiaging effects of resveratrol and vitamin D.
d-Galactose induced aging Resveratrol 1,25-dihydroxyvitamin D Klotho Antioxidant
This is a preview of subscription content, log in to check access.
This article was extracted from a Master’s thesis in Elderly health by the author Ali Dehghani, and was supported by Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Human and animal rights
All of the experiments were performed according to Animal Ethics Committee of Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
For this type of study informed consent was not required.
Corsetti G, Pasini E, Scarabelli TM et al (2016) Decreased expression of Klotho in cardiac atria biopsy samples from patients at higher risk of atherosclerotic cardiovascular disease. J Geriatr Cardiol 13:701–711PubMedPubMedCentralGoogle Scholar
Judd SE, Nanes MS, Ziegler TR et al (2008) Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 87:136–141CrossRefGoogle Scholar
Schleithoff SS, Zittermann A, Tenderich G et al (2006) Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 83:754–759CrossRefGoogle Scholar
Chekalina NI (2017) Resveratrol has a positive effect on parameters of central hemodynamics and myocardial ischemia in patients with stable coronary heart disease. Wiad Lek 70:286–291PubMedGoogle Scholar
Sharifi Klishadi M, Zarei F, Shekarforoush S et al (2014) Therapeutic effects of 1,25-dihydroxyvitamin D and losartan co-administration on myocardial ischemia-reperfusion injury in rats. Physiol Pharmacol 18:156–169Google Scholar
Beauchamp C, Fridovich I (1971) Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 44:276–287CrossRefGoogle Scholar
Mokni M, Hamlaoui S, Karkouch I et al (2013) Resveratrol provides cardioprotection after Ischemia/reperfusion injury via modulation of antioxidant enzyme activities. Iran J Pharm Res 12:867–875PubMedPubMedCentralGoogle Scholar
Yang B, Ma S, Wang YB et al (2016) Resveratrol exerts protective effects on anoxia/reoxygenation injury in cardiomyocytes via miR-34a/Sirt1 signaling pathway. Eur Rev Med Pharmacol Sci 20:2734–2741PubMedGoogle Scholar
Arking DE, Atzmon G, Arking A et al (2005) Association between a functional variant of the Klotho gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ Res 96:412–418CrossRefGoogle Scholar
Tsujikawa H, Kurotaki Y, Fujimori T et al (2003) Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol 17:2393–2403CrossRefGoogle Scholar
Forster RE, Jurutka PW, Hsieh JC et al (2011) Vitamin D receptor controls expression of the anti-aging klotho gene in mouse and human renal cells. Biochem Biophys Res Commun 414:557–562CrossRefGoogle Scholar